Zoetis Inc. (LON:0M3Q)
London · Delayed Price · Currency is GBP · Price in USD 146.93
+3.73 (2.60%)
At close: Sep 30, 2025
Zoetis Employees
Zoetis had 13,800 employees as of December 31, 2024. The number of employees decreased by 300 or -2.13% compared to the previous year.
Employees
13,800
Change (1Y)
-300
Growth (1Y)
-2.13%
Revenue / Employee
496.38K GBP
Profits / Employee
138.15K GBP
Market Cap
48.15B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13,800 | -300 | -2.13% |
| Dec 31, 2023 | 14,100 | 300 | 2.17% |
| Dec 31, 2022 | 13,800 | 1,700 | 14.05% |
| Dec 31, 2021 | 12,100 | 800 | 7.08% |
| Dec 31, 2020 | 11,300 | 700 | 6.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Genus | 3,500 |
Zoetis News
- 3 days ago - Zoetis: Much Bark, Little Bite - The Stock Remains Pricey - Seeking Alpha
- 3 days ago - Top 15 High-Growth Dividend Stocks For October 2025 - Seeking Alpha
- 5 days ago - Zoetis (ZTS) Gains FDA Nod for Innovative Livestock Parasite Treatment - GuruFocus
- 5 days ago - Zoetis granted conditional approval of Dectomax-CA1 for parasitic infection in cattle - Seeking Alpha
- 5 days ago - Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle - Business Wire
- 5 days ago - Zoetis (ZTS) Gains Conditional FDA Approval for Cattle Treatment - GuruFocus
- 8 days ago - ZTS Quantitative Stock Analysis - Warren Buffett - Nasdaq
- 9 days ago - Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth Knowing - Nasdaq